Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
Adult
Chlamydia Infections
/ complications
Chlamydia trachomatis
/ isolation & purification
France
/ epidemiology
Gonorrhea
/ complications
HIV
/ isolation & purification
HIV Infections
/ complications
HIV Seropositivity
Humans
Male
Mass Screening
/ trends
Middle Aged
Neisseria gonorrhoeae
/ isolation & purification
Sexual and Gender Minorities
/ statistics & numerical data
Sexually Transmitted Diseases
/ diagnosis
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
24
05
2020
accepted:
11
04
2021
entrez:
24
6
2021
pubmed:
25
6
2021
medline:
3
11
2021
Statut:
epublish
Résumé
The burden of STIs is particularly high in HIV-infected MSM patients. A recent increase in STIs prevalence has been noticed in the US and western European countries. We aim to assess trends in asymptomatic STIs following the publication of recommendations for STIs screening, i.e. Chlamydia (CT) and gonorrhea (NG). Seventeen centers located in the Paris area participated in the study. All asymptomatic HIV-infected MSM patients attending a follow up consultation were proposed to participated in the study. Asymptomatic patients were included over 2 periods: period 1 from April to December 2015 and period 2 from September to December 2017. Etiologic diagnosis of STIs including hepatitis B, C, syphilis, was performed using a serological test, including a non-treponemal titer with a confirmatory treponemal assay for syphilis. CT and NG were screened using a nucleic acid amplification test (NAATs) on 3 anatomical sites, i.e. urine, rectal and pharyngeal. Overall, 781 patients were included: 490 and 291 in periods 1 and 2 respectively. Asymptomatic CT, NG, and syphilis were diagnosed in 7.5%, 4.8% and, 4.2% respectively. The rate of patients having a multisite asymptomatic infection was 10.2% and 21.1% for CT and NG respectively. The most frequently involved anatomical sites for CT and NG asymptomatic infections were anorectal (66.1% and 55.2% respectively) and pharyngeal (47.4% and 60.5% respectively). CT and NG asymptomatic infection increased by 1.3- and 2-fold respectively between the two periods while syphilis decreased by 3 folds. Our results encourage to reconsider multisite screening for CT and NG in asymptomatic HIV positive MSM as the yield of screening urinary samples only might be low. Despite the more systematic STI screening of asymptomatic HIV positive MSM the prevalence of STI is increasing in MSM in France. Therefore, this strategy has not led to alter CT and NG transmission. The decrease of syphilis might involve self-medication by doxycycline, and the intensification of syphilis screening.
Identifiants
pubmed: 34166379
doi: 10.1371/journal.pone.0250557
pii: PONE-D-20-15558
pmc: PMC8224955
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0250557Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Pers Assess. 1994 Jun;62(3):385-97
pubmed: 8027907
Sex Transm Dis. 2011 Jan;38(1):12-7
pubmed: 20739912
Rev Prat. 2018 Oct;68(8):849-854
pubmed: 30869447
Med Mal Infect. 2017 Nov;47(7):490-493
pubmed: 28943174
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
AIDS. 2018 Aug 24;32(13):1871-1879
pubmed: 29927787
Int J STD AIDS. 2018 Aug;29(9):842-850
pubmed: 29514561
Euro Surveill. 2017 Feb 2;22(5):
pubmed: 28183392
Sex Transm Dis. 2017 Sep;44(9):547-550
pubmed: 28809772
JAMA. 2016 Jul 12;316(2):171-81
pubmed: 27404185
Lancet Infect Dis. 2018 Mar;18(3):308-317
pubmed: 29229440
Clin Infect Dis. 2017 Sep 15;65(6):1053-1054
pubmed: 28510643
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Lancet HIV. 2017 Sep;4(9):e402-e410
pubmed: 28747274
Lancet HIV. 2018 Sep;5(9):e482
pubmed: 30215346
Am J Trop Med Hyg. 2017 Sep;97(3):923-926
pubmed: 28820696
Euro Surveill. 2012 Jan 12;17(2):
pubmed: 22264862
BMJ Open. 2018 Jul 23;8(7):e020336
pubmed: 30037863
Infection. 2018 Jun;46(3):341-347
pubmed: 29460228
Clin Infect Dis. 2020 Sep 12;71(6):1461-1468
pubmed: 31629365
J Clin Med. 2014 Dec 12;3(4):1386-91
pubmed: 26237608
Clin Infect Dis. 2020 Apr 15;70(9):1966-1972
pubmed: 31198933
Sex Transm Dis. 2018 Sep;45(9):615-622
pubmed: 29485537
PLoS One. 2018 Oct 15;13(10):e0205863
pubmed: 30321236
AIDS. 2000;14 Suppl 3:S101-14
pubmed: 11086853
PLoS Pathog. 2017 Jul 13;13(7):e1006495
pubmed: 28704569
Sex Transm Dis. 2002 May;29(5):285-7
pubmed: 11984445
Euro Surveill. 2019 Jan;24(5):
pubmed: 30722812
Emerg Infect Dis. 2018 Feb;24(2):193-200
pubmed: 29350138